Navigation Links
MedQuist Adds Kevin Piltz as New Chief Information Officer
Date:6/18/2009

MOUNT LAUREL, N.J., June 18 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ) has announced it has added Kevin Piltz to its senior executive team as its new Chief Information Officer.

"As CIO, Kevin will be responsible for ensuring the company's information technology and development resources are aligned with its strategic and operational objectives, as well as ensuring our technology solutions will allow for profitable revenue and market share growth," says Peter Masanotti, President and Chief Executive Officer. "His experience and knowledge will ensure that MedQuist is poised to help healthcare facilities adopt innovative technology that will improve patient care and capitalize on economic stimulus incentives in the years ahead."

Piltz, 51, brings with him more than 29 years of experience, having held many different senior level technology/IT leadership positions across a variety of different industries. He was most recently the CIO for Geller and Company, a provider of accounting and financial services. He was previously the CIO of ITDS, a provider of information solutions to the communications and IP industry.

Kevin Piltz holds a bachelor's degree from Ball State University, with a major in Business and a minor in Computer Science.

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE MedQuist Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedQuist Reports First Quarter 2009 Results
2. MedQuist Names Dominick J. Golio as Chief Financial Officer
3. MedQuist Names Alan J. Gold as Senior Vice President, Sales and Marketing
4. MedQuist Announces Entry of Final Judgment Approving Settlement and Dismissing Medical Transcriptionist Class Action
5. MedQuist Announces Resolution of SEC Investigation
6. MedQuist Reports Fourth Quarter and Year End 2008 Results
7. MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits
8. New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations
9. MedQuist and Primordial to Demonstrate Integrated Applications at RSNA
10. MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology
11. MedQuist Introduces SpeechQ for Radiology Integrated with RadWorkFlow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy ... the preferred physical therapy provider for Derby City CrossFit, effective immediately. , In ... as quickly and effectively as possible, ProRehab’s sports physical therapists will work with ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... contracted partners to help with process innovation in drug formulation and manufacturing. ... along with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care to ... preventative care with all my patients to alleviate possible future issues. I am pleased to ... my office and my trained staff will assist you in any way possible.” , Dr. ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Conference at the InterContinental Hotel in Boston, ... Biomet will present at 11:20 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:4/20/2017)... -- Research and Markets has announced the addition of ... Expanding Injectables Market and Increasing Usage of Complex Biologics during the ... ... from USD 20 Billion in 2015 to around USD 26 Billion ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology: